Further Health Technology Assessments
In addition to our TAR and ESG programmes of work we also undertake further HTAs directly funded by the National Institute of Health and Care Research (NIHR) and other organisations:
Ablative and non-invasive therapies for early and very early hepatocellular carcinoma: a systematic review and network meta-analysis
Coenzyme Q10 to manage chronic heart failure with a reduced ejection fraction: a systematic review and economic evaluation
Interventions based on early intensive applied behaviour analysis for autistic children: a systematic review and cost-effectiveness analysis
Imaging tests for the detection of osteomyelitis: a systematic review
Interventional management of hyperhidrosis: a systematic review and value of information analysis
IPD meta-analysis evaluating progestogen for prevention of preterm birth